Your browser doesn't support javascript.
loading
Functional Impact of the G279S Substitution in the Adenosine A1-Receptor (A1R-G279S7.44), a Mutation Associated with Parkinson's Disease.
Nasrollahi-Shirazi, Shahrooz; Szöllösi, Daniel; Yang, Qiong; Muratspahic, Edin; El-Kasaby, Ali; Sucic, Sonja; Stockner, Thomas; Nanoff, Christian; Freissmuth, Michael.
Affiliation
  • Nasrollahi-Shirazi S; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Szöllösi D; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Yang Q; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Muratspahic E; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • El-Kasaby A; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Sucic S; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Stockner T; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Nanoff C; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Freissmuth M; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria michael.freissmuth@meduniwien.ac.at.
Mol Pharmacol ; 98(3): 250-266, 2020 09.
Article in En | MEDLINE | ID: mdl-32817461
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Amino Acid Substitution / Receptor, Adenosine A1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mol Pharmacol Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Amino Acid Substitution / Receptor, Adenosine A1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mol Pharmacol Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United States